# app/core/ontology_engine/patient_ontology.yaml

ecog_ps:
  0:
    concept: ECOG_0
  1:
    concept: ECOG_1
  2:
    concept: ECOG_2


pd_l1_tps:
  "0%":
    concept: PDL1_NEGATIVE
  "<1%":
    concept: PDL1_NEGATIVE
  "1-49%":
    concept: PDL1_LOW
  ">=50%":
    concept: PDL1_HIGH
  ">70%":
    concept: PDL1_HIGH
  ">90%":
    concept: PDL1_HIGH



brain_metastasis_status:
  none:
    concept: No_CNS_disease
  treated_stable:
    concept: Stable_CNS_disease
  active_symptomatic:
    concept: Active_CNS_disease

histology:
  adenocarcinoma:
    concept: NSCLC
  squamous:
    concept: NSCLC
  nonsquamous:
    concept: NSCLC
  small_cell:
    concept: SCLC


current_stage:
  II:
    concept: Stage_II
  III:
    concept: Stage_III
  IIIA:
    concept: Stage_III
  IIIa:
    concept: Stage_III
  IIIB:
    concept: Stage_III
  IIIb:
    concept: Stage_III
  IIIC:
    concept: Stage_III
  IIIc:
    concept: Stage_III
  IV:
    concept: Stage_IV
  IVa:
    concept: Stage_IV
  IVb:
    concept: Stage_IV
  IVc:
    concept: Stage_IV


line_of_therapy:
  1L:
    concept: First_line
  2L:
    concept: Second_line
  ">=3L":
    concept: Later_line
  adjuvant:
    concept: Adjuvant
  neoadjuvant:
    concept: Neoadjuvant

biomarkers:
  ALK_REARRANGEMENT:
    concept: DRIVER_ALK

  STK11:
    concept: STK11_MUTATION

  KRAS_G12C:
    concept: DRIVER_KRAS_G12C

  EGFR_EXON19_DEL:
    concept: DRIVER_EGFR_SENSITIZING
  EGFR_L858R:
    concept: DRIVER_EGFR_SENSITIZING
  EGFR_T790M:
    concept: DRIVER_EGFR_RESISTANCE

  MET_AMPLIFICATION:
    concept: DRIVER_MET

  HER2_EXON20:
    concept: DRIVER_HER2_ACTIVATING
  HER2_MUT:
    concept: DRIVER_HER2_ACTIVATING
  HER2_TKD:
    concept: DRIVER_HER2_ACTIVATING
  HER2_ACTIVATING:
    concept: DRIVER_HER2_ACTIVATING

  ERBB2_EXON20:
    concept: DRIVER_HER2_ACTIVATING
  ERBB2_TKD:
    concept: DRIVER_HER2_ACTIVATING

  TP53_MUT:
    concept: DRIVER_TP53
